G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,808,098 | -42.2% | 1,950,068 | 0.0% | 0.00% | – |
Q2 2023 | $4,855,669 | -9.0% | 1,950,068 | -2.0% | 0.00% | – |
Q1 2023 | $5,335,277 | -49.0% | 1,990,775 | +3.4% | 0.00% | – |
Q4 2022 | $10,457,339 | -50.4% | 1,925,845 | +14.2% | 0.00% | -100.0% |
Q3 2022 | $21,063,000 | +163.1% | 1,686,453 | +4.1% | 0.00% | – |
Q2 2022 | $8,006,000 | -45.2% | 1,620,501 | -15.8% | 0.00% | – |
Q1 2022 | $14,620,000 | -43.7% | 1,923,704 | -24.4% | 0.00% | -100.0% |
Q4 2021 | $25,979,000 | -22.8% | 2,544,365 | +1.5% | 0.00% | 0.0% |
Q3 2021 | $33,631,000 | -38.8% | 2,506,068 | +0.1% | 0.00% | 0.0% |
Q2 2021 | $54,912,000 | -6.5% | 2,502,826 | +2.5% | 0.00% | -50.0% |
Q1 2021 | $58,731,000 | +55.8% | 2,440,985 | +16.5% | 0.00% | +100.0% |
Q4 2020 | $37,702,000 | +61.6% | 2,095,727 | +3.8% | 0.00% | 0.0% |
Q3 2020 | $23,325,000 | -53.3% | 2,019,420 | -1.8% | 0.00% | -50.0% |
Q2 2020 | $49,908,000 | +121.0% | 2,057,211 | +0.4% | 0.00% | +100.0% |
Q1 2020 | $22,582,000 | -57.6% | 2,049,087 | +1.8% | 0.00% | -50.0% |
Q4 2019 | $53,219,000 | +17.3% | 2,013,565 | +1.1% | 0.00% | 0.0% |
Q3 2019 | $45,387,000 | -25.1% | 1,992,343 | +0.8% | 0.00% | 0.0% |
Q2 2019 | $60,603,000 | +94.6% | 1,976,615 | +5.4% | 0.00% | +100.0% |
Q1 2019 | $31,143,000 | -4.3% | 1,876,092 | +10.4% | 0.00% | 0.0% |
Q4 2018 | $32,548,000 | -63.8% | 1,699,652 | -1.1% | 0.00% | -75.0% |
Q3 2018 | $89,821,000 | +112.2% | 1,717,733 | +76.3% | 0.00% | +100.0% |
Q2 2018 | $42,336,000 | +13.7% | 974,137 | -3.1% | 0.00% | 0.0% |
Q1 2018 | $37,229,000 | +144.2% | 1,004,831 | +30.8% | 0.00% | +100.0% |
Q4 2017 | $15,247,000 | +155.6% | 768,468 | +220.6% | 0.00% | – |
Q3 2017 | $5,966,000 | +362.1% | 239,711 | +223.9% | 0.00% | – |
Q2 2017 | $1,291,000 | – | 74,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |